Allergan Aesthetics

Allergan Aesthetics, an AbbVie company, develops and markets a leading portfolio of medical aesthetic products. Core offerings include advanced facial injectables, such as neurotoxins and dermal fillers, alongside solutions for body contouring. The company focuses on providing scientifically backed, non-surgical options for aesthetic enhancement.

The current structure of Allergan Aesthetics emerged from AbbVie Inc.'s strategic acquisition of Allergan plc, finalized on May 8, 2020. This integration brought Allergan's established aesthetics division into AbbVie's biopharmaceutical enterprise. The insight aimed to broaden AbbVie's market reach and capitalize on Allergan's leadership in medical aesthetics.

The company's products serve healthcare professionals like dermatologists and plastic surgeons, who treat individuals seeking cosmetic improvements. Allergan Aesthetics aims to advance aesthetic science, delivering innovative, clinically proven treatments that empower patients and practitioners, fostering confidence through responsible innovation.